Ruffin, Ayana T.
Cillo, Anthony R. http://orcid.org/0000-0002-3213-3129
Tabib, Tracy
Liu, Angen
Onkar, Sayali
Kunning, Sheryl R.
Lampenfeld, Caleb
Atiya, Huda I.
Abecassis, Irina
Kürten, Cornelius H. L. http://orcid.org/0000-0002-2720-0075
Qi, Zengbiao
Soose, Ryan
Duvvuri, Umamaheswar
Kim, Seungwon
Oesterrich, Steffi http://orcid.org/0000-0002-2537-6923
Lafyatis, Robert
Coffman, Lan G. http://orcid.org/0000-0002-3753-1652
Ferris, Robert L.
Vignali, Dario A. A. http://orcid.org/0000-0002-2771-5992
Bruno, Tullia C. http://orcid.org/0000-0002-6433-0207
Article History
Received: 13 May 2020
Accepted: 21 April 2021
First Online: 7 June 2021
Competing interests
: D.A.A.V.: cofounder and stockholder—Novasenta, Tizona and Potenza; stockholder—Oncorus and Werewolf; patents licensed and royalties—Astellas, BMS; scientific advisory board member—Tizona, Werewolf and F-Star; consultant—Astellas, BMS, Almirall, Incyte, Bicara; research funding—BMS, Astellas and Novasenta. R.L.F.: a consultant for Aduro Biotech Inc., Bain Capital Life Sciences, Iovance Biotherapeutics Inc., Nanobiotix, Ono Pharmaceutical Co. Ltd., Torque Therapeutics Inc., and TTMS; is on the advisory board for Amgen, AstraZeneca/MedImmune, Bristol-Myers Squibb, EMB Serono, GlaxoSmithKline, Lilly, MacroGenics, Merck, Numab Therapeutics AG, Pfizer, PPD, Regeneron Pharmaceuticals Inc., and Tesaro; receives clinical trial support from AstraZeneca/MedImmune, Bristol-Myers Squibb, and Merck; and receives research funding from Astra-Zeneca/MedImmune, Bristol-Myers Squibb, Tesaro, TTMS, and VentiRx Pharmaceuticals. T.C.B.: Receives research support from Alkermes and Pfizer. A.T.R., A.R.C., T.T., A.L., SaO, S.R.K., C.L., H.A., C.H.L.K., Z.Q., I.A., U.D., S.K., StO, L.G.C., R.S., R.L. declare no competing financial interests.